Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Tkacz

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2019
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β<sub>2</sub>-agonist via dry-powder inhalers and pressurized metered-dose inhalersEric T Wittbrodt, Lauren A Millette, Kristin A Evans, et al.
Journal of Managed Care & Specialty Pharmacy|October 3, 2024
Evaluating estimated health care resource utilization and costs in patients with myelofibrosis based on transfusion status and anemia severity: A retrospective analysis of the Medicare Fee-For-Service claims dataAaron T Gerds, Joseph Tkacz, Laura Moore-Schiltz, et al.
The American Journal of Managed Care|August 18, 2017
Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomesCharles Ruetsch, Joseph Tkacz, Vijay R Nadipelli, et al.
The American Journal of Managed Care|February 12, 2014
Opioid analgesic-treated chronic pain patients at risk for problematic useJoseph Tkacz, Jacqueline Pesa, Lien Vo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2021
Clinical and economic burden of severe asthma among US patients treated with biologic therapiesJoan Reibman, Laren Tan, Chris Ambrose, et al.
The American Journal of Managed Care|June 23, 2022
Clinical and economic burden of uncontrolled severe noneosinophilic asthmaLaren Tan, Joan Reibman, Chris Ambrose, et al.
Blood|June 20, 2023
Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphomaDai Chihara, Laura Liao, Joseph Tkacz, et al.
Breast Cancer Research and Treatment|March 10, 2021
Variations in breast cancer surgical treatment and timing: determinants and disparitiesIrene Dankwa-Mullan, Judy George, M Christopher Roebuck, et al.
Leukemia & Lymphoma|April 10, 2020
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapyJoseph Tkacz, Jacob Garcia, Mathew Gitlin, et al.
The American Journal of Managed Care|July 27, 2021
Association of physician specialty with psoriatic arthritis treatment and costsErvant J Maksabedian Hernandez, Joseph Tkacz, Nicole M Zimmerman, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2019
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β<sub>2</sub>-agonist via dry-powder inhalers and pressurized metered-dose inhalersEric T Wittbrodt, Lauren A Millette, Kristin A Evans, et al.
Journal of Managed Care & Specialty Pharmacy|October 3, 2024
Evaluating estimated health care resource utilization and costs in patients with myelofibrosis based on transfusion status and anemia severity: A retrospective analysis of the Medicare Fee-For-Service claims dataAaron T Gerds, Joseph Tkacz, Laura Moore-Schiltz, et al.
The American Journal of Managed Care|August 18, 2017
Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomesCharles Ruetsch, Joseph Tkacz, Vijay R Nadipelli, et al.
The American Journal of Managed Care|February 12, 2014
Opioid analgesic-treated chronic pain patients at risk for problematic useJoseph Tkacz, Jacqueline Pesa, Lien Vo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2021
Clinical and economic burden of severe asthma among US patients treated with biologic therapiesJoan Reibman, Laren Tan, Chris Ambrose, et al.
The American Journal of Managed Care|June 23, 2022
Clinical and economic burden of uncontrolled severe noneosinophilic asthmaLaren Tan, Joan Reibman, Chris Ambrose, et al.
Blood|June 20, 2023
Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphomaDai Chihara, Laura Liao, Joseph Tkacz, et al.
Breast Cancer Research and Treatment|March 10, 2021
Variations in breast cancer surgical treatment and timing: determinants and disparitiesIrene Dankwa-Mullan, Judy George, M Christopher Roebuck, et al.
Leukemia & Lymphoma|April 10, 2020
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapyJoseph Tkacz, Jacob Garcia, Mathew Gitlin, et al.
The American Journal of Managed Care|July 27, 2021
Association of physician specialty with psoriatic arthritis treatment and costsErvant J Maksabedian Hernandez, Joseph Tkacz, Nicole M Zimmerman, et al.
Pageof 6